Sandy Srinivas
University of California, Irvine · 337 works · 23,445 citations · h-index 64
Top works
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- Prostate Cancer
- Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
- Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
- Prostate Cancer, Version 1.2016
- Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
- Prostate Cancer, Version 2.2014
- The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer
- The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
- NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
- Randomized Phase II Study of Erlotinib Combined With Bevacizumab Compared With Bevacizumab Alone in Metastatic Renal Cell Cancer
- EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
- NCCN Task Force Report: Bone Health in Cancer Care
- Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
- Vinflunine in platinum‐pretreated patients with locally advanced or metastatic urothelial carcinoma
- Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate